Alliance For Cancer Gene Therapy Inc
- Assets
- $7.0m
- Revenue
- $3.3m
- Investments
- $0.0
- Employees
- 2
- Location
- Stamford, CT
- Founding
- 07/2001
- Data as of
- 04/2022
- EIN
- 06-1619523
Organization Overview
Alliance For Cancer Gene Therapy Inc is located in Stamford, CT. The organization was established in 2001. According to its NTEE Classification (T30) the organization is classified as: Public Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. As of 04/2022, Alliance For Cancer Gene Therapy Inc employed 2 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Alliance For Cancer Gene Therapy Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 04/2022, Alliance For Cancer Gene Therapy Inc generated $3.3m in total revenue. This organization has experienced exceptional growth, as over the past 6 years, it has increased revenue by an average of 15.8% each year . All expenses for the organization totaled $1.8m during the year ending 04/2022. While expenses have increased by 1.5% per year over the past 6 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2021, Alliance For Cancer Gene Therapy Inc has awarded 22 individual grants totaling $4,756,416. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
ALLIANCE FOR CANCER GENE THERAPY FUNDS INNOVATIVE SCIENTISTS WORKING TO(CONTINUED ON SCHEDULE O)(CONTINUED)HARNESS THE POWER OF CELL AND GENE THERAPY TO TRANSFORM HOW CANCER IS TREATED AND DRIVE MOMENTUM TOWARDS A CURE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
IN FYE 04/30/21, ACGT FUNDED CLINICAL INVESTIGATOR GRANTS (AWARDS TO INVESTIGATOR CONDUCTING CLINICAL TRANSLATION) AT PREMIER ACADEMIC INSTITUTIONS IN THE U.S., EACH FOCUSING ON CANCER CELL AND GENE THERAPIES FOR DIFFERENT CANCERS: LUNG, PANCREATIC, PROSTATE, OVARIAN AND PEDIATRIC SARCOMA. IN ADDITION, ACGT BEGAN A MULTI-YEAR COLLABORATION WITH TWO OTHER 501(C)3 ORGANIZATIONS FOCUSED ON CELL AND GENE THERAPY RESEARCH FOR GLIOBLASTOMA. THROUGHOUT THE YEAR, ACGT ALSO FURTHER INCREASED PUBLIC AWARENESS OF CELL AND GENE THERAPY RESEARCH THROUGH SCIENTIFIC SEMINARS, ACGT'S WEBSITE, SOCIAL MEDIA, AND MARKETING MATERIALS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Barbara Lavery Chief Program Officer | Officer | 40 | $222,470 |
Kevin Honeycutt President & CEO | OfficerTrustee | 40 | $0 |
H William Smith Vice President, Legal, Sec | Officer | 2 | $0 |
Christine Herman Vice President, Treasurer | Officer | 2 | $0 |
Barbara Netter Honorary Chairman | Trustee | 6 | $0 |
Andrew Alisberg Director | Trustee | 1 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Mintz Levin Cohn Ferris Glovsky And Legal | 4/29/21 | $198,610 |
Mito Pop Brand Consultant | 4/29/21 | $114,614 |
Mintz Levin Cohn Ferris Glovsky And Legal | 4/29/21 | $198,610 |
Mito Pop Brand Consultant | 4/29/21 | $114,614 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $9,428 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $2,444,951 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $2,454,379 |
| Total Program Service Revenue | $0 |
| Investment income | $73,459 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $161,669 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $534,254 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $3,295,905 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $1,237,350 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $254,803 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $3,428 |
| Other employee benefits | $13,597 |
| Payroll taxes | $14,911 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $39,427 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $56,844 |
| Advertising and promotion | $15,257 |
| Office expenses | $32,962 |
| Information technology | $77,310 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $24,129 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $3,279 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $0 |
| All other expenses | $30,924 |
| Total functional expenses | $1,804,221 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $329,616 |
| Savings and temporary cash investments | $2,731,260 |
| Pledges and grants receivable | $13,771 |
| Accounts receivable, net | $62 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $115,176 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $3,828,652 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $7,018,537 |
| Accounts payable and accrued expenses | $41,923 |
| Grants payable | $1,199,610 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $1,241,533 |
| Net assets without donor restrictions | $3,541,227 |
| Net assets with donor restrictions | $2,235,777 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $7,018,537 |
Grants Awarded
Over the last fiscal year, Alliance For Cancer Gene Therapy Inc has awarded $1,237,350 in support to 6 organizations.
| Grant Recipient | Amount |
|---|---|
New York, NY PURPOSE: CANCER RESEARCH | $750,009 |
Pittsburgh, PA PURPOSE: CANCER RESEARCH | $481,942 |
Philadelphia, PA PURPOSE: CANCER RESEARCH | $1,957 |
Memphis, TN PURPOSE: CANCER RESEARCH | $1,878 |
New Haven, CT PURPOSE: CANCER RESEARCH | $891 |
New York, NY PURPOSE: CANCER RESEARCH | $673 |
Grants Recieved
Over the last fiscal year, we have identified 1 grants that Alliance For Cancer Gene Therapy Inc has recieved totaling $8,000.
| Awarding Organization | Amount |
|---|---|
Scrivan Family Foundation Wilmington, DE PURPOSE: GENERAL & UNRESTRICTED | $8,000 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Partnership Schools New York, NY | $64,379,139 | $24,282,663 |
Royal College Of Art Usa Inc New York, NY | $1,933,182 | $14,916,047 |
Imago Dei Fund Boston, MA | $57,020,766 | $29,637,241 |
Boston Charitable Trust Fund Boston, MA | $1,173,216 | $4,494,143 |
Nfa Foundation Inc Norwich, CT | $77,129,817 | $5,415,738 |
American Friends Of B Nai Levy Foundation Brooklyn, NY | $493,786 | $13,431,000 |
Rf Catalytic Capital Inc New York, NY | $241,603,034 | $246,273,218 |
Freedom Fund Brooklyn, NY | $51,719,352 | $51,201,158 |
Provision Ministry Inc Westborough, MA | $833,220 | $12,247,682 |
Student Leadership Network Inc New York, NY | $11,626,545 | $12,224,104 |
The Good Nation Foundation Inc New York, NY | $2,105,948 | $9,558,970 |
New York Times Neediest Cases Fund New York, NY | $66,331,518 | $11,554,497 |